Przejdź do treści

Cochrane method or tool interest form

Proposals to change methods and tools are assessed by the Methods Executive following the process outlined on the Cochrane Methods website

Person completing this form
List all Cochrane groups and entities with which you are affiliated using separate rows.
List lead researchers or developers, if known, using separate rows.
Briefly detail why you think Cochrane should consider the method or tool and how you envision it being used in Cochrane reviews. Please state whether your proposal is to replace an existing method or if it is to be used in parallel with current methods. If the latter, please state which existing methods this new approach should complement or be used alongside. Please state if you are seeking Cochrane’s approval, endorsement, mandate or other (<200 words).
Briefly detail which Methods Groups you have been in contact with and describe the level of collaboration and any support for the development of your proposal, if any. A list of the Methods Groups can be found here (<200 words).
Briefly describe the aims and objectives of the method or development (<200 words).
Briefly describe the key features of the method or development or methodological problem. Please state whether the method should be applied in standard Cochrane reviews, specific types of reviews or whether more experimental (<300 words).
Briefly detail the strengths and limitations of the method or tool, including scenarios when it is best suited and when it may be inappropriate to use. This is particularly important for methods and tools using artificial intelligence.
Briefly highlight any potential implementation considerations you envision, including, but not limited to; developments to Cochrane systems or tools, e.g. RevMan functionality or integration; specific requirement for publications and how it is visualised; whether it generates large datasets, how these should be managed and whether they should be published; any costs associated with its use; any ethical or other legal considerations, e.g., copyright, privacy, etc. for authors or Cochrane; and requirements for training authors, editors and/or peer reviewers, etc.   
Briefly describe support from published guidance or evaluation of the method or tool with information on its development and acceptability (<200 words). If applicable, please list primary references. You can upload unpublished documents, such as proof of performance, details of testing or piloting, information on the acceptability of the method or tool, or other guidance using the link below. 
Files must be less than 2 MB. Allowed file types: html pdf doc docx ppt pptx xls xlsx.
Tylko jeden plik.
Limit 2 MB.
Dozwolone rozszerzenia: html, pdf, doc, docx, ppt, pptx, xls, xlsx.

Używamy plików cookie

Używamy niezbędnych plików cookie, aby nasza strona mogła działać. Chcielibyśmy również ustawić opcjonalne pliki cookie do analizy, aby pomóc nam udoskonalić tę stronę. Nie będziemy ustawiać opcjonalnych plików cookie, chyba że je włączysz. Użycie tego narzędzia spowoduje ustawienie pliku cookie na Twoim urządzeniu, aby zapamiętać Twoje preferencje. W każdej chwili możesz zmienić swoje preferencje dotyczące plików cookie, klikając na link "Ustawienia plików cookie" znajdujący się w stopce każdej strony.
Bardziej szczegółowe informacje na temat używanych przez nas plików cookie można znaleźć na naszej stronieStrona plików cookies

Zaakceptuj wszystkie
Skonfiguruj